

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.61910364 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.61910364 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.48230147 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.48230147 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.62302379 |
| 6 | sulfur amino acid catabolic process (GO:0000098) | 5.38373069 |
| 7 | lysine catabolic process (GO:0006554) | 5.22121193 |
| 8 | lysine metabolic process (GO:0006553) | 5.22121193 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 5.20479319 |
| 10 | glyoxylate metabolic process (GO:0046487) | 5.10579759 |
| 11 | cysteine metabolic process (GO:0006534) | 5.01987516 |
| 12 | bile acid biosynthetic process (GO:0006699) | 4.96894481 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.93418365 |
| 14 | kynurenine metabolic process (GO:0070189) | 4.79164980 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 4.73923738 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 4.73923738 |
| 17 | tryptophan catabolic process (GO:0006569) | 4.73923738 |
| 18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.60860165 |
| 19 | cellular ketone body metabolic process (GO:0046950) | 4.59252897 |
| 20 | urea metabolic process (GO:0019627) | 4.57174252 |
| 21 | urea cycle (GO:0000050) | 4.57174252 |
| 22 | tryptophan metabolic process (GO:0006568) | 4.55269122 |
| 23 | amino-acid betaine metabolic process (GO:0006577) | 4.49890972 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 4.47774099 |
| 25 | bile acid metabolic process (GO:0008206) | 4.37873901 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.24737763 |
| 27 | protein carboxylation (GO:0018214) | 4.24737763 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 4.22520773 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 4.20272865 |
| 30 | ethanol oxidation (GO:0006069) | 4.18942130 |
| 31 | complement activation, alternative pathway (GO:0006957) | 4.17941752 |
| 32 | alpha-amino acid catabolic process (GO:1901606) | 4.15388041 |
| 33 | acylglycerol homeostasis (GO:0055090) | 4.14071381 |
| 34 | triglyceride homeostasis (GO:0070328) | 4.14071381 |
| 35 | 2-oxoglutarate metabolic process (GO:0006103) | 4.12074809 |
| 36 | regulation of protein activation cascade (GO:2000257) | 4.09869847 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 4.08857374 |
| 38 | glutamate metabolic process (GO:0006536) | 4.07964376 |
| 39 | tyrosine metabolic process (GO:0006570) | 4.06926507 |
| 40 | serine family amino acid catabolic process (GO:0009071) | 4.05643210 |
| 41 | proline biosynthetic process (GO:0006561) | 4.02653800 |
| 42 | valine metabolic process (GO:0006573) | 4.01813203 |
| 43 | DNA double-strand break processing (GO:0000729) | 3.99915364 |
| 44 | regulation of fibrinolysis (GO:0051917) | 3.99655027 |
| 45 | cellular amino acid catabolic process (GO:0009063) | 3.99426867 |
| 46 | short-chain fatty acid metabolic process (GO:0046459) | 3.99352199 |
| 47 | fatty acid beta-oxidation (GO:0006635) | 3.96119999 |
| 48 | ketone body metabolic process (GO:1902224) | 3.95857477 |
| 49 | homocysteine metabolic process (GO:0050667) | 3.95192909 |
| 50 | regulation of relaxation of muscle (GO:1901077) | 3.93211330 |
| 51 | reverse cholesterol transport (GO:0043691) | 3.89163575 |
| 52 | plasma lipoprotein particle remodeling (GO:0034369) | 3.83903665 |
| 53 | protein-lipid complex remodeling (GO:0034368) | 3.83903665 |
| 54 | macromolecular complex remodeling (GO:0034367) | 3.83903665 |
| 55 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.83895465 |
| 56 | regulation of complement activation (GO:0030449) | 3.81351903 |
| 57 | fatty acid oxidation (GO:0019395) | 3.81185402 |
| 58 | regulation of triglyceride catabolic process (GO:0010896) | 3.80007670 |
| 59 | carnitine metabolic process (GO:0009437) | 3.77378291 |
| 60 | imidazole-containing compound metabolic process (GO:0052803) | 3.76065553 |
| 61 | coenzyme catabolic process (GO:0009109) | 3.75892389 |
| 62 | benzene-containing compound metabolic process (GO:0042537) | 3.75404869 |
| 63 | aspartate family amino acid catabolic process (GO:0009068) | 3.73801235 |
| 64 | monocarboxylic acid catabolic process (GO:0072329) | 3.73310755 |
| 65 | lipid oxidation (GO:0034440) | 3.72928028 |
| 66 | acetyl-CoA metabolic process (GO:0006084) | 3.72810868 |
| 67 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.72545945 |
| 68 | fatty acid catabolic process (GO:0009062) | 3.72340086 |
| 69 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.71444278 |
| 70 | oxaloacetate metabolic process (GO:0006107) | 3.70950013 |
| 71 | succinate metabolic process (GO:0006105) | 3.70651958 |
| 72 | response to nitrosative stress (GO:0051409) | 3.70076040 |
| 73 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.69070332 |
| 74 | proline metabolic process (GO:0006560) | 3.68170428 |
| 75 | carboxylic acid catabolic process (GO:0046395) | 3.67541820 |
| 76 | organic acid catabolic process (GO:0016054) | 3.67541820 |
| 77 | cellular modified amino acid catabolic process (GO:0042219) | 3.63745580 |
| 78 | cholesterol efflux (GO:0033344) | 3.60241402 |
| 79 | protein localization to cilium (GO:0061512) | 3.58762535 |
| 80 | cytolysis (GO:0019835) | 3.55643946 |
| 81 | plasma lipoprotein particle assembly (GO:0034377) | 3.50166656 |
| 82 | xenobiotic catabolic process (GO:0042178) | 3.49328937 |
| 83 | bile acid and bile salt transport (GO:0015721) | 3.49049973 |
| 84 | regulation of cholesterol esterification (GO:0010872) | 3.48715324 |
| 85 | alkaloid metabolic process (GO:0009820) | 3.48157076 |
| 86 | intestinal cholesterol absorption (GO:0030299) | 3.47350389 |
| 87 | cellular glucuronidation (GO:0052695) | 3.44345256 |
| 88 | indolalkylamine metabolic process (GO:0006586) | 3.44182389 |
| 89 | regulation of cell communication by electrical coupling (GO:0010649) | 3.42237859 |
| 90 | positive regulation of glycolytic process (GO:0045821) | 3.41465996 |
| 91 | serine family amino acid metabolic process (GO:0009069) | 3.40431719 |
| 92 | presynaptic membrane assembly (GO:0097105) | 3.38683004 |
| 93 | fatty acid transmembrane transport (GO:1902001) | 3.38607091 |
| 94 | drug transmembrane transport (GO:0006855) | 3.38429320 |
| 95 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.38170167 |
| 96 | response to pheromone (GO:0019236) | 3.36275564 |
| 97 | phospholipid efflux (GO:0033700) | 3.33832113 |
| 98 | branched-chain amino acid catabolic process (GO:0009083) | 3.32958471 |
| 99 | regulation of cholesterol homeostasis (GO:2000188) | 3.32227254 |
| 100 | glycine metabolic process (GO:0006544) | 3.30570542 |
| 101 | regulation of protein glycosylation (GO:0060049) | 3.30432194 |
| 102 | tricarboxylic acid metabolic process (GO:0072350) | 3.28716489 |
| 103 | branched-chain amino acid metabolic process (GO:0009081) | 3.28685805 |
| 104 | drug catabolic process (GO:0042737) | 3.25214130 |
| 105 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.23462177 |
| 106 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.23462177 |
| 107 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.22363277 |
| 108 | plasma lipoprotein particle clearance (GO:0034381) | 3.21497612 |
| 109 | NAD biosynthetic process (GO:0009435) | 3.20829792 |
| 110 | neural tube formation (GO:0001841) | 3.14047034 |
| 111 | regulation of hexokinase activity (GO:1903299) | 3.11217865 |
| 112 | regulation of glucokinase activity (GO:0033131) | 3.11217865 |
| 113 | nucleobase catabolic process (GO:0046113) | 3.10212842 |
| 114 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.09463801 |
| 115 | establishment of protein localization to Golgi (GO:0072600) | 2.99813389 |
| 116 | inositol phosphate catabolic process (GO:0071545) | 2.99464807 |
| 117 | protein targeting to Golgi (GO:0000042) | 2.97897306 |
| 118 | presynaptic membrane organization (GO:0097090) | 2.97540163 |
| 119 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.95456043 |
| 120 | intraciliary transport (GO:0042073) | 2.94118415 |
| 121 | lipid particle organization (GO:0034389) | 2.84427668 |
| 122 | histone H2A acetylation (GO:0043968) | 2.79414380 |
| 123 | neuron cell-cell adhesion (GO:0007158) | 2.74912250 |
| 124 | nonmotile primary cilium assembly (GO:0035058) | 2.71497837 |
| 125 | regulation of sarcomere organization (GO:0060297) | 2.71165011 |
| 126 | histone mRNA catabolic process (GO:0071044) | 2.68485174 |
| 127 | dopamine transport (GO:0015872) | 2.67606074 |
| 128 | proline transport (GO:0015824) | 2.65955935 |
| 129 | detection of calcium ion (GO:0005513) | 2.63633352 |
| 130 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.63546840 |
| 131 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.63546840 |
| 132 | keratinocyte development (GO:0003334) | 2.62126527 |
| 133 | reflex (GO:0060004) | 2.60574440 |
| 134 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.60293115 |
| 135 | positive regulation of mitochondrial fission (GO:0090141) | 2.59663710 |
| 136 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.58988814 |
| 137 | prostate gland growth (GO:0060736) | 2.58383248 |
| 138 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.57572896 |
| 139 | inositol phosphate dephosphorylation (GO:0046855) | 2.57572896 |
| 140 | ribonucleoprotein complex disassembly (GO:0032988) | 2.57539794 |
| 141 | cullin deneddylation (GO:0010388) | 2.55591057 |
| 142 | protein K11-linked deubiquitination (GO:0035871) | 2.54280801 |
| 143 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.52773240 |
| 144 | righting reflex (GO:0060013) | 2.52455981 |
| 145 | protein localization to Golgi apparatus (GO:0034067) | 2.51982638 |
| 146 | gamma-aminobutyric acid transport (GO:0015812) | 2.51582275 |
| 147 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.50692632 |
| 148 | brain morphogenesis (GO:0048854) | 2.50058690 |
| 149 | muscle filament sliding (GO:0030049) | 2.49753885 |
| 150 | actin-myosin filament sliding (GO:0033275) | 2.49753885 |
| 151 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.49569539 |
| 152 | retinal cone cell development (GO:0046549) | 2.47567221 |
| 153 | dendritic spine morphogenesis (GO:0060997) | 2.47051441 |
| 154 | acrosome assembly (GO:0001675) | 2.46761978 |
| 155 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.46685513 |
| 156 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.45800539 |
| 157 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.45156701 |
| 158 | negative regulation of neurotransmitter transport (GO:0051589) | 2.44198648 |
| 159 | neurotransmitter uptake (GO:0001504) | 2.43865635 |
| 160 | glycosphingolipid biosynthetic process (GO:0006688) | 2.42693010 |
| 161 | cilium organization (GO:0044782) | 2.41741251 |
| 162 | regulation of actin filament-based movement (GO:1903115) | 2.38578823 |
| 163 | cilium assembly (GO:0042384) | 2.38081164 |
| 164 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.36423349 |
| 165 | neuron fate determination (GO:0048664) | 2.35761227 |
| 166 | regulation of dendritic spine development (GO:0060998) | 2.35620019 |
| 167 | cilium morphogenesis (GO:0060271) | 2.35550693 |
| 168 | C4-dicarboxylate transport (GO:0015740) | 2.34111815 |
| 169 | neuronal action potential propagation (GO:0019227) | 2.34083681 |
| 170 | limb bud formation (GO:0060174) | 2.33630743 |
| 171 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.33280593 |
| 172 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.32487688 |
| 173 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.32487688 |
| 174 | acrosome reaction (GO:0007340) | 2.31448991 |
| 175 | polyol catabolic process (GO:0046174) | 2.30872553 |
| 176 | regulation of sulfur metabolic process (GO:0042762) | 2.29420767 |
| 177 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.28480158 |
| 178 | negative regulation of DNA recombination (GO:0045910) | 2.28373919 |
| 179 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.27450715 |
| 180 | actin-mediated cell contraction (GO:0070252) | 2.27127895 |
| 181 | Golgi to endosome transport (GO:0006895) | 2.26586281 |
| 182 | protein K63-linked deubiquitination (GO:0070536) | 2.26370024 |
| 183 | prenylation (GO:0097354) | 2.25995021 |
| 184 | protein prenylation (GO:0018342) | 2.25995021 |
| 185 | signal peptide processing (GO:0006465) | 2.25442914 |
| 186 | growth hormone receptor signaling pathway (GO:0060396) | 2.25030817 |
| 187 | regulation of oligodendrocyte differentiation (GO:0048713) | 2.24786766 |
| 188 | peptidyl-histidine modification (GO:0018202) | 2.23908195 |
| 189 | olfactory bulb development (GO:0021772) | 2.23857274 |
| 190 | anterograde synaptic vesicle transport (GO:0048490) | 2.23665507 |
| 191 | positive regulation of mRNA processing (GO:0050685) | 2.22787579 |
| 192 | atrial cardiac muscle cell action potential (GO:0086014) | 2.22541772 |
| 193 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.21517247 |
| 194 | inner ear receptor stereocilium organization (GO:0060122) | 2.19697294 |
| 195 | cellular component assembly involved in morphogenesis (GO:0010927) | 2.19192817 |
| 196 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.18382386 |
| 197 | auditory behavior (GO:0031223) | 2.17913913 |
| 198 | axoneme assembly (GO:0035082) | 2.17091520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.71827266 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.47791420 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.69405494 |
| 4 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.37175953 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.30292835 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.76680606 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.75223037 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.02341746 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.74186439 |
| 10 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 3.41461334 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.02135737 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.97430213 |
| 13 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.96157640 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.96131599 |
| 15 | FUS_26573619_Chip-Seq_HEK293_Human | 2.71535311 |
| 16 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.66876213 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.62531791 |
| 18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.42386486 |
| 19 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.40789165 |
| 20 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.38868364 |
| 21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.35057491 |
| 22 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.30676934 |
| 23 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.21083923 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 2.19120244 |
| 25 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.17176818 |
| 26 | P300_19829295_ChIP-Seq_ESCs_Human | 2.10143026 |
| 27 | VDR_22108803_ChIP-Seq_LS180_Human | 2.09791009 |
| 28 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.07584207 |
| 29 | * EWS_26573619_Chip-Seq_HEK293_Human | 2.03530593 |
| 30 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.01688905 |
| 31 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4507374 |
| 32 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.97516072 |
| 33 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.93672402 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.93570892 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.93392238 |
| 36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.86503889 |
| 37 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.85548176 |
| 38 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.82960971 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.80910693 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.78939861 |
| 41 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.78182647 |
| 42 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.77390793 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.73519291 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.71180006 |
| 45 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.70167417 |
| 46 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.68026884 |
| 47 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.67985600 |
| 48 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.64377158 |
| 49 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.64377158 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.64369440 |
| 51 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.64279396 |
| 52 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.64142559 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.62886361 |
| 54 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.59506674 |
| 55 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.57549920 |
| 56 | STAT3_23295773_ChIP-Seq_U87_Human | 1.55581204 |
| 57 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.53794740 |
| 58 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.52378408 |
| 59 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.52107924 |
| 60 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50709622 |
| 61 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.48184145 |
| 62 | AR_25329375_ChIP-Seq_VCAP_Human | 1.46664019 |
| 63 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.46606873 |
| 64 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.45548519 |
| 65 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.45241860 |
| 66 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.42239207 |
| 67 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.41986450 |
| 68 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.40675139 |
| 69 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39755598 |
| 70 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.39302606 |
| 71 | TCF4_23295773_ChIP-Seq_U87_Human | 1.38880812 |
| 72 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.33942311 |
| 73 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.33892988 |
| 74 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.32045897 |
| 75 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.32029216 |
| 76 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.30815096 |
| 77 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.26842270 |
| 78 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.26402026 |
| 79 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.26183357 |
| 80 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.26179170 |
| 81 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.25658272 |
| 82 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.25586299 |
| 83 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.25569861 |
| 84 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.24436735 |
| 85 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.24436735 |
| 86 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21333429 |
| 87 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.20932986 |
| 88 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.19961298 |
| 89 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.19929732 |
| 90 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.19797689 |
| 91 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.19797689 |
| 92 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.19742199 |
| 93 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.18878194 |
| 94 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.18350041 |
| 95 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.17573521 |
| 96 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.16316436 |
| 97 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.16060218 |
| 98 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.16058468 |
| 99 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.15213864 |
| 100 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.15039258 |
| 101 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.13705079 |
| 102 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.13568731 |
| 103 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.11843402 |
| 104 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.11135645 |
| 105 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.10632649 |
| 106 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09502035 |
| 107 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.09502035 |
| 108 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.08381465 |
| 109 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.07854058 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03571854 |
| 111 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03187717 |
| 112 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.02206126 |
| 113 | KDM2B_26808549_Chip-Seq_REH_Human | 1.02169928 |
| 114 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.00895605 |
| 115 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.00234916 |
| 116 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.00187532 |
| 117 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99960818 |
| 118 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.99650660 |
| 119 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.99606371 |
| 120 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.98930931 |
| 121 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.98907104 |
| 122 | TBL1_22424771_ChIP-Seq_293T_Human | 0.98091607 |
| 123 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.98055691 |
| 124 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.97989272 |
| 125 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.97213828 |
| 126 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.93185044 |
| 127 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.92441103 |
| 128 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.90593964 |
| 129 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89514957 |
| 130 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88826870 |
| 131 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88545396 |
| 132 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.88349019 |
| 133 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87867825 |
| 134 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.87229038 |
| 135 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.85857875 |
| 136 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.82761895 |
| 137 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.81257669 |
| 138 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.80661220 |
| 139 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78210978 |
| 140 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77975088 |
| 141 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76924328 |
| 142 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75320298 |
| 143 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.74606948 |
| 144 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.73696273 |
| 145 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.72200920 |
| 146 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.71332689 |
| 147 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.69151548 |
| 148 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.68155701 |
| 149 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.68123234 |
| 150 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.67614807 |
| 151 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.67573102 |
| 152 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.67346349 |
| 153 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.67222625 |
| 154 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.66211997 |
| 155 | GATA2_19941826_ChIP-Seq_K562_Human | 0.65615126 |
| 156 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.64031855 |
| 157 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.63197076 |
| 158 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.60766712 |
| 159 | AR_20517297_ChIP-Seq_VCAP_Human | 0.60366152 |
| 160 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.60014994 |
| 161 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.59815732 |
| 162 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.58957320 |
| 163 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.58950997 |
| 164 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.56878792 |
| 165 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.56543720 |
| 166 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.54843091 |
| 167 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.53569970 |
| 168 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.53476233 |
| 169 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.53402976 |
| 170 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.51836906 |
| 171 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.51643912 |
| 172 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.51107779 |
| 173 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50823767 |
| 174 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.50021529 |
| 175 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.49123032 |
| 176 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.48889417 |
| 177 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.48553636 |
| 178 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.47940326 |
| 179 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.47767972 |
| 180 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.47296354 |
| 181 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.47170346 |
| 182 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.46435632 |
| 183 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.46075288 |
| 184 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.45125289 |
| 185 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44299915 |
| 186 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.44281913 |
| 187 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.44234025 |
| 188 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.44192596 |
| 189 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.43997372 |
| 190 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.43811445 |
| 191 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.43573455 |
| 192 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.40681431 |
| 193 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.40387164 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.26823771 |
| 2 | MP0005365_abnormal_bile_salt | 6.27986236 |
| 3 | MP0005360_urolithiasis | 5.98768853 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.86647644 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.82818797 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.81504453 |
| 7 | MP0003252_abnormal_bile_duct | 3.57682846 |
| 8 | MP0003195_calcinosis | 3.22280895 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.20627528 |
| 10 | MP0003880_abnormal_central_pattern | 3.04301020 |
| 11 | MP0005083_abnormal_biliary_tract | 2.98200495 |
| 12 | MP0000569_abnormal_digit_pigmentation | 2.95290685 |
| 13 | MP0004145_abnormal_muscle_electrophysio | 2.88132550 |
| 14 | MP0003656_abnormal_erythrocyte_physiolo | 2.62381647 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.53574373 |
| 16 | MP0004270_analgesia | 2.53359229 |
| 17 | MP0005332_abnormal_amino_acid | 2.43794576 |
| 18 | MP0003787_abnormal_imprinting | 2.34200382 |
| 19 | MP0008877_abnormal_DNA_methylation | 2.32230741 |
| 20 | MP0002102_abnormal_ear_morphology | 2.24516685 |
| 21 | MP0002638_abnormal_pupillary_reflex | 2.07494796 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 2.05830098 |
| 23 | MP0001984_abnormal_olfaction | 2.02874597 |
| 24 | MP0000609_abnormal_liver_physiology | 1.99057594 |
| 25 | MP0003868_abnormal_feces_composition | 1.96997908 |
| 26 | MP0001764_abnormal_homeostasis | 1.96807877 |
| 27 | MP0009840_abnormal_foam_cell | 1.95116719 |
| 28 | MP0002837_dystrophic_cardiac_calcinosis | 1.90145210 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.88042040 |
| 30 | MP0006276_abnormal_autonomic_nervous | 1.87351381 |
| 31 | MP0004130_abnormal_muscle_cell | 1.80891295 |
| 32 | MP0006036_abnormal_mitochondrial_physio | 1.79995478 |
| 33 | MP0009745_abnormal_behavioral_response | 1.76931476 |
| 34 | MP0009046_muscle_twitch | 1.72425358 |
| 35 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.69074202 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.67831861 |
| 37 | MP0001486_abnormal_startle_reflex | 1.62625590 |
| 38 | MP0004142_abnormal_muscle_tone | 1.62100952 |
| 39 | MP0004147_increased_porphyrin_level | 1.60544944 |
| 40 | MP0004019_abnormal_vitamin_homeostasis | 1.59485659 |
| 41 | MP0000427_abnormal_hair_cycle | 1.59248664 |
| 42 | MP0004484_altered_response_of | 1.54756326 |
| 43 | MP0000749_muscle_degeneration | 1.54688935 |
| 44 | MP0005253_abnormal_eye_physiology | 1.54262862 |
| 45 | MP0009697_abnormal_copulation | 1.53591329 |
| 46 | MP0002272_abnormal_nervous_system | 1.50798057 |
| 47 | MP0005248_abnormal_Harderian_gland | 1.44975982 |
| 48 | MP0003122_maternal_imprinting | 1.44734420 |
| 49 | MP0003221_abnormal_cardiomyocyte_apopto | 1.43869076 |
| 50 | MP0002078_abnormal_glucose_homeostasis | 1.43316087 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.43287025 |
| 52 | MP0004084_abnormal_cardiac_muscle | 1.40770440 |
| 53 | MP0004043_abnormal_pH_regulation | 1.37453995 |
| 54 | MP0008057_abnormal_DNA_replication | 1.36853607 |
| 55 | MP0003635_abnormal_synaptic_transmissio | 1.36194252 |
| 56 | MP0005220_abnormal_exocrine_pancreas | 1.35612689 |
| 57 | MP0001188_hyperpigmentation | 1.35544797 |
| 58 | MP0002332_abnormal_exercise_endurance | 1.30372715 |
| 59 | MP0000516_abnormal_urinary_system | 1.30169771 |
| 60 | MP0005367_renal/urinary_system_phenotyp | 1.30169771 |
| 61 | MP0010234_abnormal_vibrissa_follicle | 1.30168365 |
| 62 | MP0002064_seizures | 1.28534271 |
| 63 | MP0005620_abnormal_muscle_contractility | 1.27946568 |
| 64 | MP0002876_abnormal_thyroid_physiology | 1.27486795 |
| 65 | MP0002734_abnormal_mechanical_nocicepti | 1.26249414 |
| 66 | MP0000778_abnormal_nervous_system | 1.25897221 |
| 67 | MP0004924_abnormal_behavior | 1.25569157 |
| 68 | MP0005386_behavior/neurological_phenoty | 1.25569157 |
| 69 | MP0002067_abnormal_sensory_capabilities | 1.21966102 |
| 70 | MP0003186_abnormal_redox_activity | 1.21539195 |
| 71 | MP0002063_abnormal_learning/memory/cond | 1.21429358 |
| 72 | MP0009643_abnormal_urine_homeostasis | 1.21172767 |
| 73 | MP0003121_genomic_imprinting | 1.20943434 |
| 74 | MP0008789_abnormal_olfactory_epithelium | 1.20473203 |
| 75 | MP0002572_abnormal_emotion/affect_behav | 1.18405576 |
| 76 | MP0003137_abnormal_impulse_conducting | 1.15314076 |
| 77 | MP0004085_abnormal_heartbeat | 1.14696467 |
| 78 | MP0005551_abnormal_eye_electrophysiolog | 1.14468600 |
| 79 | MP0005636_abnormal_mineral_homeostasis | 1.13911354 |
| 80 | MP0002106_abnormal_muscle_physiology | 1.13784536 |
| 81 | MP0005266_abnormal_metabolism | 1.12752512 |
| 82 | MP0000598_abnormal_liver_morphology | 1.11652640 |
| 83 | MP0010678_abnormal_skin_adnexa | 1.11646899 |
| 84 | MP0001177_atelectasis | 1.10475527 |
| 85 | MP0005535_abnormal_body_temperature | 1.09573998 |
| 86 | MP0002971_abnormal_brown_adipose | 1.09049297 |
| 87 | MP0004859_abnormal_synaptic_plasticity | 1.06337070 |
| 88 | MP0001440_abnormal_grooming_behavior | 1.05575013 |
| 89 | MP0002557_abnormal_social/conspecific_i | 1.05036133 |
| 90 | MP0000013_abnormal_adipose_tissue | 1.04903517 |
| 91 | MP0002751_abnormal_autonomic_nervous | 1.02268240 |
| 92 | MP0010386_abnormal_urinary_bladder | 1.01048449 |
| 93 | MP0002972_abnormal_cardiac_muscle | 1.00809994 |
| 94 | MP0001501_abnormal_sleep_pattern | 1.00484219 |
| 95 | MP0004811_abnormal_neuron_physiology | 0.99601086 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 0.99472794 |
| 97 | MP0006035_abnormal_mitochondrial_morpho | 0.97993885 |
| 98 | MP0000639_abnormal_adrenal_gland | 0.97407369 |
| 99 | MP0005369_muscle_phenotype | 0.97289049 |
| 100 | MP0003011_delayed_dark_adaptation | 0.96576515 |
| 101 | MP0004885_abnormal_endolymph | 0.96468049 |
| 102 | MP0001968_abnormal_touch/_nociception | 0.95889063 |
| 103 | MP0005376_homeostasis/metabolism_phenot | 0.94662270 |
| 104 | MP0002269_muscular_atrophy | 0.94052190 |
| 105 | MP0000383_abnormal_hair_follicle | 0.93290304 |
| 106 | MP0002735_abnormal_chemical_nociception | 0.92798730 |
| 107 | MP0005334_abnormal_fat_pad | 0.92351264 |
| 108 | MP0009703_decreased_birth_body | 0.90696352 |
| 109 | MP0005084_abnormal_gallbladder_morpholo | 0.90378333 |
| 110 | MP0009642_abnormal_blood_homeostasis | 0.89601382 |
| 111 | MP0002909_abnormal_adrenal_gland | 0.88148803 |
| 112 | MP0005448_abnormal_energy_balance | 0.87984840 |
| 113 | MP0002928_abnormal_bile_duct | 0.87714317 |
| 114 | MP0003953_abnormal_hormone_level | 0.86915058 |
| 115 | MP0000372_irregular_coat_pigmentation | 0.86815426 |
| 116 | MP0000631_abnormal_neuroendocrine_gland | 0.85572150 |
| 117 | MP0001529_abnormal_vocalization | 0.85027649 |
| 118 | MP0001944_abnormal_pancreas_morphology | 0.84095028 |
| 119 | MP0008058_abnormal_DNA_repair | 0.83901598 |
| 120 | MP0005647_abnormal_sex_gland | 0.83840812 |
| 121 | MP0002069_abnormal_eating/drinking_beha | 0.83733732 |
| 122 | MP0003172_abnormal_lysosome_physiology | 0.83075223 |
| 123 | MP0000647_abnormal_sebaceous_gland | 0.82025564 |
| 124 | MP0005646_abnormal_pituitary_gland | 0.79572404 |
| 125 | MP0002127_abnormal_cardiovascular_syste | 0.78024313 |
| 126 | MP0001970_abnormal_pain_threshold | 0.77376519 |
| 127 | MP0002184_abnormal_innervation | 0.77131438 |
| 128 | MP0002090_abnormal_vision | 0.75918694 |
| 129 | MP0005394_taste/olfaction_phenotype | 0.75822338 |
| 130 | MP0002693_abnormal_pancreas_physiology | 0.75352100 |
| 131 | MP0009780_abnormal_chondrocyte_physiolo | 0.74665524 |
| 132 | MP0004233_abnormal_muscle_weight | 0.73520371 |
| 133 | MP0002822_catalepsy | 0.72655733 |
| 134 | MP0004215_abnormal_myocardial_fiber | 0.71351496 |
| 135 | MP0002970_abnormal_white_adipose | 0.70908319 |
| 136 | MP0001756_abnormal_urination | 0.70060483 |
| 137 | MP0009763_increased_sensitivity_to | 0.69788315 |
| 138 | MP0002009_preneoplasia | 0.69275553 |
| 139 | MP0005330_cardiomyopathy | 0.68655956 |
| 140 | MP0003646_muscle_fatigue | 0.65602634 |
| 141 | MP0009764_decreased_sensitivity_to | 0.63835603 |
| 142 | MP0004264_abnormal_extraembryonic_tissu | 0.62010025 |
| 143 | MP0008872_abnormal_physiological_respon | 0.60681472 |
| 144 | MP0008961_abnormal_basal_metabolism | 0.60588600 |
| 145 | MP0000604_amyloidosis | 0.59547444 |
| 146 | MP0008469_abnormal_protein_level | 0.59214432 |
| 147 | MP0005670_abnormal_white_adipose | 0.59051148 |
| 148 | MP0005187_abnormal_penis_morphology | 0.58942878 |
| 149 | MP0003959_abnormal_lean_body | 0.58304883 |
| 150 | MP0009115_abnormal_fat_cell | 0.57631744 |
| 151 | MP0005058_abnormal_lysosome_morphology | 0.57522676 |
| 152 | MP0003633_abnormal_nervous_system | 0.56116387 |
| 153 | MP0000003_abnormal_adipose_tissue | 0.55800440 |
| 154 | MP0009765_abnormal_xenobiotic_induced | 0.54789397 |
| 155 | MP0001502_abnormal_circadian_rhythm | 0.53188352 |
| 156 | MP0005464_abnormal_platelet_physiology | 0.52972843 |
| 157 | MP0003638_abnormal_response/metabolism_ | 0.52856226 |
| 158 | MP0001545_abnormal_hematopoietic_system | 0.51849374 |
| 159 | MP0005397_hematopoietic_system_phenotyp | 0.51849374 |
| 160 | MP0008874_decreased_physiological_sensi | 0.51751049 |
| 161 | MP0005666_abnormal_adipose_tissue | 0.47603140 |
| 162 | MP0002166_altered_tumor_susceptibility | 0.47283527 |
| 163 | MP0005645_abnormal_hypothalamus_physiol | 0.47081723 |
| 164 | MP0000751_myopathy | 0.46511943 |
| 165 | MP0003300_gastrointestinal_ulcer | 0.46088270 |
| 166 | MP0000747_muscle_weakness | 0.44453194 |
| 167 | MP0005452_abnormal_adipose_tissue | 0.44240449 |
| 168 | MP0004036_abnormal_muscle_relaxation | 0.42170336 |
| 169 | MP0006072_abnormal_retinal_apoptosis | 0.42134668 |
| 170 | MP0000371_diluted_coat_color | 0.41738535 |
| 171 | MP0000230_abnormal_systemic_arterial | 0.41704322 |
| 172 | MP0005075_abnormal_melanosome_morpholog | 0.40952517 |
| 173 | MP0001765_abnormal_ion_homeostasis | 0.40229374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.52267184 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.77211067 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 5.20765631 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.19224639 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.13513343 |
| 6 | Hypoglycemic coma (HP:0001325) | 5.08201651 |
| 7 | Ketosis (HP:0001946) | 4.74300150 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.60512777 |
| 9 | Ketoacidosis (HP:0001993) | 4.59809399 |
| 10 | Xanthomatosis (HP:0000991) | 4.57720072 |
| 11 | Hyperammonemia (HP:0001987) | 4.22937949 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 3.95805559 |
| 13 | Hypolipoproteinemia (HP:0010981) | 3.92239023 |
| 14 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.91742795 |
| 15 | Calf muscle hypertrophy (HP:0008981) | 3.87341272 |
| 16 | Medial flaring of the eyebrow (HP:0010747) | 3.84173494 |
| 17 | Abnormality of the intrinsic pathway (HP:0010989) | 3.70799113 |
| 18 | Gait imbalance (HP:0002141) | 3.68589637 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 3.64959308 |
| 20 | Exercise-induced muscle cramps (HP:0003710) | 3.63507272 |
| 21 | Hypoglycemic seizures (HP:0002173) | 3.59823384 |
| 22 | Nemaline bodies (HP:0003798) | 3.56675613 |
| 23 | Fat malabsorption (HP:0002630) | 3.56365680 |
| 24 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.56317416 |
| 25 | Congenital primary aphakia (HP:0007707) | 3.55893788 |
| 26 | Hyperbilirubinemia (HP:0002904) | 3.53997669 |
| 27 | Complement deficiency (HP:0004431) | 3.53470820 |
| 28 | Muscle fiber inclusion bodies (HP:0100299) | 3.52728309 |
| 29 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.52043971 |
| 30 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.46824363 |
| 31 | Hyperglycinemia (HP:0002154) | 3.42247765 |
| 32 | Epidermoid cyst (HP:0200040) | 3.41069950 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 3.35687398 |
| 34 | Hypochromic microcytic anemia (HP:0004840) | 3.32458675 |
| 35 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.30811419 |
| 36 | Nephrogenic diabetes insipidus (HP:0009806) | 3.21421306 |
| 37 | Hyperglycinuria (HP:0003108) | 3.21253429 |
| 38 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.15811775 |
| 39 | Abnormality of methionine metabolism (HP:0010901) | 3.14903430 |
| 40 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.13759357 |
| 41 | Joint hemorrhage (HP:0005261) | 3.11147351 |
| 42 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.07763168 |
| 43 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.05340061 |
| 44 | Abnormality of glycine metabolism (HP:0010895) | 3.05340061 |
| 45 | Genital tract atresia (HP:0001827) | 3.02426129 |
| 46 | Conjugated hyperbilirubinemia (HP:0002908) | 3.00714808 |
| 47 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.93112329 |
| 48 | Myoglobinuria (HP:0002913) | 2.87514293 |
| 49 | Metabolic acidosis (HP:0001942) | 2.84166943 |
| 50 | Thyroiditis (HP:0100646) | 2.82675046 |
| 51 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.81039855 |
| 52 | Delayed CNS myelination (HP:0002188) | 2.76640354 |
| 53 | Vaginal atresia (HP:0000148) | 2.76491123 |
| 54 | Late onset (HP:0003584) | 2.74741164 |
| 55 | Hypothermia (HP:0002045) | 2.74277030 |
| 56 | Gout (HP:0001997) | 2.73906366 |
| 57 | Steatorrhea (HP:0002570) | 2.73508637 |
| 58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.72106656 |
| 59 | Dicarboxylic aciduria (HP:0003215) | 2.72106656 |
| 60 | Generalized aminoaciduria (HP:0002909) | 2.71320395 |
| 61 | Abnormality of serum amino acid levels (HP:0003112) | 2.69455359 |
| 62 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.68843927 |
| 63 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.68843927 |
| 64 | Abnormal gallbladder morphology (HP:0012437) | 2.67702104 |
| 65 | Abnormality of the calf musculature (HP:0001430) | 2.65163900 |
| 66 | Pancreatic fibrosis (HP:0100732) | 2.64347169 |
| 67 | Symptomatic seizures (HP:0011145) | 2.63014931 |
| 68 | Methylmalonic acidemia (HP:0002912) | 2.62193151 |
| 69 | Acanthocytosis (HP:0001927) | 2.60565937 |
| 70 | Cholelithiasis (HP:0001081) | 2.60305296 |
| 71 | Atonic seizures (HP:0010819) | 2.60057725 |
| 72 | Rimmed vacuoles (HP:0003805) | 2.57081034 |
| 73 | Pancreatic cysts (HP:0001737) | 2.55962074 |
| 74 | Hypercholesterolemia (HP:0003124) | 2.54897870 |
| 75 | Lethargy (HP:0001254) | 2.52296388 |
| 76 | Febrile seizures (HP:0002373) | 2.51576709 |
| 77 | Cerebral edema (HP:0002181) | 2.50674755 |
| 78 | Poor coordination (HP:0002370) | 2.48514072 |
| 79 | Hepatocellular carcinoma (HP:0001402) | 2.48346936 |
| 80 | Abnormality of purine metabolism (HP:0004352) | 2.45792615 |
| 81 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.45240739 |
| 82 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.45240739 |
| 83 | Poikilocytosis (HP:0004447) | 2.44366930 |
| 84 | Abnormality of nucleobase metabolism (HP:0010932) | 2.44336277 |
| 85 | Abnormality of complement system (HP:0005339) | 2.41766546 |
| 86 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.41423601 |
| 87 | True hermaphroditism (HP:0010459) | 2.38724196 |
| 88 | Curly hair (HP:0002212) | 2.38239383 |
| 89 | Papillary thyroid carcinoma (HP:0002895) | 2.37445273 |
| 90 | Growth hormone excess (HP:0000845) | 2.36269439 |
| 91 | Hyperglycemia (HP:0003074) | 2.35965100 |
| 92 | Skin nodule (HP:0200036) | 2.35667086 |
| 93 | Progressive inability to walk (HP:0002505) | 2.35445879 |
| 94 | Difficulty running (HP:0009046) | 2.29778384 |
| 95 | Hyperventilation (HP:0002883) | 2.29058185 |
| 96 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.25398433 |
| 97 | Neonatal onset (HP:0003623) | 2.24075431 |
| 98 | Fair hair (HP:0002286) | 2.23947126 |
| 99 | Specific learning disability (HP:0001328) | 2.22284035 |
| 100 | Tubulointerstitial nephritis (HP:0001970) | 2.20555996 |
| 101 | Hepatic necrosis (HP:0002605) | 2.19918861 |
| 102 | Drooling (HP:0002307) | 2.19645683 |
| 103 | Irritability (HP:0000737) | 2.18053040 |
| 104 | Acute hepatic failure (HP:0006554) | 2.16313101 |
| 105 | Large for gestational age (HP:0001520) | 2.15830799 |
| 106 | Spastic diplegia (HP:0001264) | 2.14493426 |
| 107 | Vomiting (HP:0002013) | 2.12743189 |
| 108 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.11585472 |
| 109 | Limb dystonia (HP:0002451) | 2.10774073 |
| 110 | Inability to walk (HP:0002540) | 2.10191020 |
| 111 | Proximal amyotrophy (HP:0007126) | 2.10123577 |
| 112 | Pheochromocytoma (HP:0002666) | 2.08541810 |
| 113 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.07956508 |
| 114 | Turricephaly (HP:0000262) | 2.07612565 |
| 115 | Volvulus (HP:0002580) | 2.07357968 |
| 116 | Nephronophthisis (HP:0000090) | 2.07012691 |
| 117 | Abnormality of the gallbladder (HP:0005264) | 2.06078922 |
| 118 | Brushfield spots (HP:0001088) | 2.05265300 |
| 119 | Thyroid carcinoma (HP:0002890) | 2.04032776 |
| 120 | Status epilepticus (HP:0002133) | 2.03504119 |
| 121 | Broad-based gait (HP:0002136) | 2.03463269 |
| 122 | Excessive salivation (HP:0003781) | 2.01890419 |
| 123 | Focal motor seizures (HP:0011153) | 2.00416499 |
| 124 | Dialeptic seizures (HP:0011146) | 1.99007858 |
| 125 | Gaze-evoked nystagmus (HP:0000640) | 1.97935605 |
| 126 | Abnormality of the renal cortex (HP:0011035) | 1.97347745 |
| 127 | Abnormality of the renal medulla (HP:0100957) | 1.95175975 |
| 128 | Exercise-induced myalgia (HP:0003738) | 1.93757771 |
| 129 | Hemiparesis (HP:0001269) | 1.92415357 |
| 130 | Abnormal gallbladder physiology (HP:0012438) | 1.92399255 |
| 131 | Cholecystitis (HP:0001082) | 1.92399255 |
| 132 | EEG with generalized epileptiform discharges (HP:0011198) | 1.90569690 |
| 133 | Muscular hypotonia of the trunk (HP:0008936) | 1.90494440 |
| 134 | Frequent falls (HP:0002359) | 1.90395543 |
| 135 | Hypsarrhythmia (HP:0002521) | 1.90313297 |
| 136 | Myocardial infarction (HP:0001658) | 1.90241393 |
| 137 | Spontaneous abortion (HP:0005268) | 1.89594015 |
| 138 | Progressive macrocephaly (HP:0004481) | 1.89556251 |
| 139 | Polycythemia (HP:0001901) | 1.89552671 |
| 140 | Palpitations (HP:0001962) | 1.89433178 |
| 141 | Limb hypertonia (HP:0002509) | 1.89394673 |
| 142 | Increased muscle lipid content (HP:0009058) | 1.88928185 |
| 143 | Dyskinesia (HP:0100660) | 1.88306169 |
| 144 | Ragged-red muscle fibers (HP:0003200) | 1.87423541 |
| 145 | Generalized hyperpigmentation (HP:0007440) | 1.87111155 |
| 146 | Epileptiform EEG discharges (HP:0011182) | 1.87108001 |
| 147 | Molar tooth sign on MRI (HP:0002419) | 1.86861472 |
| 148 | Abnormality of midbrain morphology (HP:0002418) | 1.86861472 |
| 149 | Focal seizures (HP:0007359) | 1.86512054 |
| 150 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.85983175 |
| 151 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.85983175 |
| 152 | Pancreatitis (HP:0001733) | 1.85342871 |
| 153 | Left ventricular hypertrophy (HP:0001712) | 1.83470391 |
| 154 | Stomach cancer (HP:0012126) | 1.83167482 |
| 155 | Neuroendocrine neoplasm (HP:0100634) | 1.82990041 |
| 156 | Mitral stenosis (HP:0001718) | 1.81829749 |
| 157 | Mucopolysacchariduria (HP:0008155) | 1.81336662 |
| 158 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.81336662 |
| 159 | Pelvic girdle muscle weakness (HP:0003749) | 1.80620306 |
| 160 | Renal cortical cysts (HP:0000803) | 1.80505570 |
| 161 | Methylmalonic aciduria (HP:0012120) | 1.79320876 |
| 162 | Oligomenorrhea (HP:0000876) | 1.76785493 |
| 163 | Proximal tubulopathy (HP:0000114) | 1.76634429 |
| 164 | Rhabdomyolysis (HP:0003201) | 1.76532569 |
| 165 | Sensorimotor neuropathy (HP:0007141) | 1.76011538 |
| 166 | Postaxial hand polydactyly (HP:0001162) | 1.75669862 |
| 167 | Opisthotonus (HP:0002179) | 1.75411716 |
| 168 | EMG: myopathic abnormalities (HP:0003458) | 1.75128722 |
| 169 | Tongue fasciculations (HP:0001308) | 1.75000854 |
| 170 | Cerebral palsy (HP:0100021) | 1.74869110 |
| 171 | Decreased testicular size (HP:0008734) | 1.74156897 |
| 172 | Abnormality of vitamin B metabolism (HP:0004340) | 1.73958951 |
| 173 | Abnormality of the metopic suture (HP:0005556) | 1.73167362 |
| 174 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.72091654 |
| 175 | Shoulder girdle muscle weakness (HP:0003547) | 1.71100824 |
| 176 | Severe combined immunodeficiency (HP:0004430) | 1.70869467 |
| 177 | Absent speech (HP:0001344) | 1.69571822 |
| 178 | Prominent metopic ridge (HP:0005487) | 1.68674048 |
| 179 | Widely spaced teeth (HP:0000687) | 1.68653378 |
| 180 | Amyotrophic lateral sclerosis (HP:0007354) | 1.68051344 |
| 181 | Oligodactyly (hands) (HP:0001180) | 1.67123779 |
| 182 | Colon cancer (HP:0003003) | 1.66017736 |
| 183 | Abnormality of macular pigmentation (HP:0008002) | 1.65610061 |
| 184 | Broad foot (HP:0001769) | 1.63911986 |
| 185 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.62982122 |
| 186 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.62568908 |
| 187 | Ulnar claw (HP:0001178) | 1.60847072 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.16785150 |
| 2 | INSRR | 4.37514901 |
| 3 | BMPR1B | 3.92350163 |
| 4 | MAPK15 | 3.51219983 |
| 5 | FLT3 | 3.01064921 |
| 6 | CASK | 2.77589829 |
| 7 | PINK1 | 2.76727547 |
| 8 | SIK1 | 2.72205354 |
| 9 | TRIM28 | 2.60891682 |
| 10 | MAP3K6 | 2.48527353 |
| 11 | BCR | 2.47313599 |
| 12 | PDK4 | 2.34653430 |
| 13 | PDK3 | 2.34653430 |
| 14 | MAP3K11 | 2.16357318 |
| 15 | MKNK2 | 2.07915760 |
| 16 | MAP2K4 | 2.07863463 |
| 17 | ERN1 | 2.06815846 |
| 18 | DAPK1 | 2.01985473 |
| 19 | MAP4K2 | 1.98751285 |
| 20 | PKN2 | 1.97886610 |
| 21 | TRIB3 | 1.92699652 |
| 22 | MARK1 | 1.92388288 |
| 23 | TAOK3 | 1.88797190 |
| 24 | FRK | 1.85779016 |
| 25 | AKT3 | 1.83929748 |
| 26 | PIK3CG | 1.83522887 |
| 27 | TGFBR1 | 1.77061076 |
| 28 | FGFR4 | 1.73362066 |
| 29 | NEK1 | 1.73337954 |
| 30 | DYRK1B | 1.69521712 |
| 31 | MAPK11 | 1.56100658 |
| 32 | MKNK1 | 1.56063099 |
| 33 | PLK2 | 1.54399232 |
| 34 | TNIK | 1.53056215 |
| 35 | MAP3K4 | 1.48522984 |
| 36 | HIPK2 | 1.45523217 |
| 37 | ICK | 1.39642138 |
| 38 | EIF2AK3 | 1.37378863 |
| 39 | SCYL2 | 1.37163576 |
| 40 | FGFR2 | 1.36957931 |
| 41 | MST4 | 1.36948461 |
| 42 | MAP3K12 | 1.35666446 |
| 43 | BRSK2 | 1.35629610 |
| 44 | RPS6KA4 | 1.35097193 |
| 45 | DAPK2 | 1.34897855 |
| 46 | MAPK13 | 1.34695218 |
| 47 | CSNK1G2 | 1.28652082 |
| 48 | PHKG1 | 1.27171889 |
| 49 | PHKG2 | 1.27171889 |
| 50 | CSNK1G1 | 1.26777680 |
| 51 | CDK8 | 1.23856215 |
| 52 | MATK | 1.17857025 |
| 53 | NUAK1 | 1.17410344 |
| 54 | BRD4 | 1.16402691 |
| 55 | CSNK1G3 | 1.14836722 |
| 56 | EPHA3 | 1.14485313 |
| 57 | CDK6 | 1.10333692 |
| 58 | UHMK1 | 1.09674597 |
| 59 | FER | 1.09191859 |
| 60 | STK38L | 1.08326457 |
| 61 | EPHA4 | 1.07813823 |
| 62 | RIPK1 | 1.06069332 |
| 63 | JAK2 | 1.05428584 |
| 64 | TSSK6 | 1.05382470 |
| 65 | PRKCE | 1.05341878 |
| 66 | PRKAA1 | 1.03132854 |
| 67 | CAMKK2 | 0.99698945 |
| 68 | SRPK1 | 0.99673846 |
| 69 | NLK | 0.92792000 |
| 70 | CSNK1A1L | 0.91433911 |
| 71 | OXSR1 | 0.91149905 |
| 72 | MAPKAPK3 | 0.90896312 |
| 73 | MAP2K7 | 0.89427932 |
| 74 | MAP3K2 | 0.89421040 |
| 75 | STK24 | 0.89347618 |
| 76 | OBSCN | 0.89035338 |
| 77 | PDK2 | 0.88320651 |
| 78 | PDGFRA | 0.86237771 |
| 79 | PRKAA2 | 0.85486919 |
| 80 | MAP2K3 | 0.85250454 |
| 81 | PLK3 | 0.85042554 |
| 82 | NEK9 | 0.82515527 |
| 83 | TNK2 | 0.82245546 |
| 84 | DDR2 | 0.81555038 |
| 85 | DYRK3 | 0.78376515 |
| 86 | RPS6KL1 | 0.76795641 |
| 87 | RPS6KC1 | 0.76795641 |
| 88 | CSK | 0.75702504 |
| 89 | YES1 | 0.71828480 |
| 90 | SGK2 | 0.71675190 |
| 91 | RPS6KB1 | 0.68524909 |
| 92 | CCNB1 | 0.68192013 |
| 93 | DYRK1A | 0.67800696 |
| 94 | NTRK3 | 0.67369546 |
| 95 | RET | 0.66755335 |
| 96 | RPS6KA6 | 0.66261287 |
| 97 | SGK3 | 0.64527441 |
| 98 | CAMK2A | 0.64237382 |
| 99 | CAMKK1 | 0.64114609 |
| 100 | STK39 | 0.64089281 |
| 101 | WNK3 | 0.62526137 |
| 102 | MAPK4 | 0.60535011 |
| 103 | PKN1 | 0.58125018 |
| 104 | CAMK2G | 0.57753282 |
| 105 | KIT | 0.57604277 |
| 106 | PRKCG | 0.57180733 |
| 107 | CDK3 | 0.56495402 |
| 108 | PASK | 0.54854475 |
| 109 | ACVR1B | 0.54696491 |
| 110 | ZAK | 0.54615254 |
| 111 | FGFR3 | 0.54401069 |
| 112 | MYLK | 0.54320120 |
| 113 | PRKACG | 0.54029832 |
| 114 | NTRK2 | 0.53698495 |
| 115 | MAP3K1 | 0.52671402 |
| 116 | GSK3A | 0.52620953 |
| 117 | ERBB4 | 0.52406365 |
| 118 | GRK1 | 0.50834572 |
| 119 | MAP3K5 | 0.50519956 |
| 120 | VRK1 | 0.49868257 |
| 121 | RAF1 | 0.49601804 |
| 122 | PNCK | 0.49241773 |
| 123 | PTK6 | 0.49221620 |
| 124 | PAK6 | 0.48379087 |
| 125 | ADRBK2 | 0.48198032 |
| 126 | DYRK2 | 0.48022808 |
| 127 | TAOK2 | 0.47882227 |
| 128 | TRPM7 | 0.47816632 |
| 129 | CDK9 | 0.46945289 |
| 130 | MAP3K10 | 0.46634526 |
| 131 | IRAK1 | 0.46591826 |
| 132 | SIK3 | 0.46261556 |
| 133 | MAP3K7 | 0.46148898 |
| 134 | MINK1 | 0.45205779 |
| 135 | ERBB3 | 0.44473549 |
| 136 | BMPR2 | 0.41784628 |
| 137 | PRKG1 | 0.41246227 |
| 138 | PAK3 | 0.40365694 |
| 139 | JAK1 | 0.40204746 |
| 140 | MAP2K6 | 0.37538192 |
| 141 | CDK5 | 0.37060960 |
| 142 | KSR1 | 0.36843233 |
| 143 | CAMK2B | 0.36421632 |
| 144 | CDK19 | 0.35134447 |
| 145 | STK16 | 0.34994145 |
| 146 | RPS6KA5 | 0.34429967 |
| 147 | CAMK4 | 0.34377311 |
| 148 | MAPK3 | 0.34279327 |
| 149 | PRKCZ | 0.34220180 |
| 150 | CAMK2D | 0.33923990 |
| 151 | STK3 | 0.33490063 |
| 152 | TEC | 0.32881784 |
| 153 | RPS6KA2 | 0.31972311 |
| 154 | FGFR1 | 0.31398705 |
| 155 | TIE1 | 0.31319492 |
| 156 | MAPK12 | 0.30847540 |
| 157 | PRKACA | 0.30533593 |
| 158 | EGFR | 0.29315136 |
| 159 | MAP2K1 | 0.28639679 |
| 160 | RPS6KA3 | 0.28274512 |
| 161 | PIM2 | 0.28042861 |
| 162 | TYRO3 | 0.27251810 |
| 163 | TBK1 | 0.26539960 |
| 164 | TGFBR2 | 0.26487624 |
| 165 | SGK494 | 0.25543665 |
| 166 | SGK223 | 0.25543665 |
| 167 | KSR2 | 0.24205613 |
| 168 | TTN | 0.22426374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.91244291 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.24589284 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.17879554 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.10603121 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.94195431 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.91126274 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.69206958 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.61166375 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.56162605 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.51320466 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.36548412 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.33990312 |
| 13 | Nicotine addiction_Homo sapiens_hsa05033 | 2.30852134 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.27829263 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.27532536 |
| 16 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.23866187 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22215806 |
| 18 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.18905891 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.97876393 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.93528195 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.93028742 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.92658630 |
| 23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.71918887 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.71868362 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69589675 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.67281133 |
| 27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59193493 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.55469066 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.55200585 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55145977 |
| 31 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.54691825 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.54260762 |
| 33 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.52914579 |
| 34 | RNA degradation_Homo sapiens_hsa03018 | 1.52145068 |
| 35 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.52027652 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.51199776 |
| 37 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.48502813 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.47731418 |
| 39 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.46733461 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.43246561 |
| 41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.42709838 |
| 42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.42604434 |
| 43 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.42600009 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.39881885 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.39703485 |
| 46 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.38941208 |
| 47 | Histidine metabolism_Homo sapiens_hsa00340 | 1.38624544 |
| 48 | Circadian entrainment_Homo sapiens_hsa04713 | 1.36854990 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.35774966 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.34912035 |
| 51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.33684179 |
| 52 | Bile secretion_Homo sapiens_hsa04976 | 1.33627374 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32756328 |
| 54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.30568901 |
| 55 | Basal transcription factors_Homo sapiens_hsa03022 | 1.29791087 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 1.28025975 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 1.23846284 |
| 58 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.22811212 |
| 59 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.21662506 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.21321337 |
| 61 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.20536400 |
| 62 | Phototransduction_Homo sapiens_hsa04744 | 1.19473442 |
| 63 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.19169616 |
| 64 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.16897535 |
| 65 | Morphine addiction_Homo sapiens_hsa05032 | 1.11557918 |
| 66 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.11124748 |
| 67 | Retinol metabolism_Homo sapiens_hsa00830 | 1.09856732 |
| 68 | Taste transduction_Homo sapiens_hsa04742 | 1.03202606 |
| 69 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.02726449 |
| 70 | Long-term depression_Homo sapiens_hsa04730 | 1.02316654 |
| 71 | Cocaine addiction_Homo sapiens_hsa05030 | 1.02166808 |
| 72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.02148683 |
| 73 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.01501605 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98910613 |
| 75 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.98021629 |
| 76 | Renin secretion_Homo sapiens_hsa04924 | 0.98016065 |
| 77 | Lysine degradation_Homo sapiens_hsa00310 | 0.96809106 |
| 78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.96807042 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93928378 |
| 80 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.93191710 |
| 81 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.89011649 |
| 82 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.86031312 |
| 83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.80929728 |
| 84 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.80912503 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79095658 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77119437 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76889764 |
| 88 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.72488931 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72091206 |
| 90 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.71908932 |
| 91 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.69965277 |
| 92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64200358 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63887744 |
| 94 | Olfactory transduction_Homo sapiens_hsa04740 | 0.60160919 |
| 95 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.59394219 |
| 96 | Salivary secretion_Homo sapiens_hsa04970 | 0.57979614 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57929360 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57647513 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.56973455 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56925128 |
| 101 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55254035 |
| 102 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.55217735 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54919302 |
| 104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54459052 |
| 105 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52693049 |
| 106 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.52079172 |
| 107 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.51330000 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.51115260 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48837784 |
| 110 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.48162520 |
| 111 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47952643 |
| 112 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47588980 |
| 113 | Tight junction_Homo sapiens_hsa04530 | 0.45412011 |
| 114 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43700884 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42639046 |
| 116 | Proteasome_Homo sapiens_hsa03050 | 0.41278773 |
| 117 | Long-term potentiation_Homo sapiens_hsa04720 | 0.41265844 |
| 118 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40306040 |
| 119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.39982457 |
| 120 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.34039096 |
| 121 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.33683700 |
| 122 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.31258650 |
| 123 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.30207263 |
| 124 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.25862622 |
| 125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.20324465 |
| 126 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.17383620 |
| 127 | Insulin secretion_Homo sapiens_hsa04911 | 0.17016482 |
| 128 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.15924308 |
| 129 | Protein export_Homo sapiens_hsa03060 | 0.14496154 |
| 130 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.13816933 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.13390348 |
| 132 | Prion diseases_Homo sapiens_hsa05020 | 0.13292103 |
| 133 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.12798910 |
| 134 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.09772546 |
| 135 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.09699542 |
| 136 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.05757801 |
| 137 | Parkinsons disease_Homo sapiens_hsa05012 | 0.05497246 |
| 138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.04957909 |
| 139 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.04582209 |
| 140 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.04260702 |
| 141 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.03730796 |
| 142 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.02310718 |
| 143 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.02008931 |
| 144 | GABAergic synapse_Homo sapiens_hsa04727 | 0.01745866 |
| 145 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | -0.0783158 |
| 146 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0642032 |
| 147 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0613671 |
| 148 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0208979 |
| 149 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0188941 |

